Alvino Mark 4

What Happened
Director Mark Alvino sold 6,500 shares of Abeona Therapeutics, Inc. (ABEO) in open-market transactions on May 22, 2026. The weighted average sale price was $5.46 per share, for total proceeds of approximately $35,463. This was a sale (S) and not a purchase or option exercise.

Key Details

• Transaction date: May 22, 2026
• Shares sold: 6,500 at a weighted average price of $5.46; total proceeds ≈ $35,463
• Price range: individual trades occurred between $5.44 and $5.47 (weighted average reported; reporting person will provide per-price quantities on request)
• Transaction type: Open-market sale (S) — no indication of 10b5-1 plan, option exercise, gift, or tax withholding in this filing
• Shares owned after transaction: Not specified in this Form 4 filing
• Filing timeliness: Reported and filed on May 22, 2026 (same-day filing)

Context
Insider sales are common and can reflect many reasons (diversification, personal liquidity, routine selling), so they do not by themselves indicate a change in company fundamentals. Purchases generally carry more direct informational value for investors; this report documents a routine open-market sale by a company director.